CliffBio
small molecule

DEXTROAMPHETAMINE SULFATE

DEXTROAMPHETAMINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanyQUAGEN PHARMACEUTICALS LLC

Drug detail

Brand nameDEXTROAMPHETAMINE SULFATE
Active ingredientDEXTROAMPHETAMINE SULFATE
Strength10MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2016
Marketing statusDISCN

More from QUAGEN PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.